
Cough Miniseries
A new paradigm has emerged of patients with chronic cough that does not respond to asthma, rhinitis, and/or GERD therapy. Allergists need to understand the different therapeutic agents available now and in the future and their mechanisms of action in all stages of cough.
- Episode 1: Understanding the Cough Reflex (0:21)
- Episode 2: Diagnosing the Patient's Cough (0:30)
- Episode 3: Treatment Options in Cough (0:19)
- Expert: Mandel Sher, MD, FACAAI
Expert: Kevin Murphy, MD, FACAAI
Host: Purvi Parikh, MD
This podcast series is supported by an educational grant from Merck & Co., Inc.
PIDD Disparities Miniseries
Patients with Primary Immunodeficiency Diseases (PIDD) are not only susceptible to infection, but they are also at risk for other, non-infectious, complications. Some of these non-infectious complications can be life-threatening for the patient. This session is intended to discuss how to monitor for these complications, the pathophysiology behind these complications, and the impact new immune therapies have on management of patients with PIDD.
- Episode 1: Underdiagnosis of PIDD in Minority/Underserved Populations (0:14)
- Episode 2: Addressing the Barriers to Diagnosis of PIDD in Minority/Underserved Populations (0:18)
- Episode 3: Improving Access to Treatment for PIDD in Minority/Underserved Populations (0:24)
- Expert: Carla Davis, MD
Expert: Vivan Hernandez-Trujillo, MD
Host: Gerald Lee, MD
This podcast series is supported by Pfizer.
Atopic Dermatitis Disparities Miniseries
Atopic dermatitis is a common disease known to disproportionately impact minorities in a variety of ways. Improving access to care and increasing clinical training can help reduce barriers for underserved populations.
- Episode 1: Current Evidence for Disparities in Atopic Dermatitis (0:19)
- Episode 2: The Influence of Skin of Color in Diagnosing and Managing Patients with Atopic Dermatitis (0:22)
- Episode 3: Improving Access to Treatment for Atopic Dermatitis in Minority and Underserved Populations (0:20)
- Expert: Anil Nanda, MD, FACAAI, FAAAAI, FACP
Expert: Andrew Alexis, MD, MPH
Expert: Marcella Aquino, MD, FACAAI, FAAAAI
Host: Payel Gupta, MD, FACAAI
This podcast series is supported by Pfizer.
Disparities in Chronic Rhinosinusitis with Nasal Polyps Miniseries
CRSwNP has a significant negative impact on patients’ quality of life, affecting work productivity and sleep, and leading to social and emotional consequences, as well increased economic burden. For underserved populations there is a significant impact on morbidity as well. Minority and low-income groups are less likely to receive proper treatment.
- Episode 1: Diagnosis Disparities of Chronic Rhinosinusitis with Nasal Polyps in Minority and Underserved Populations (0:14)
- Episode 2: Impact of Environmental Triggers in CRSwNP for Minority and Underserved Populations (0:13)
- Episode 3: Access to Treatment Disparities for Nasal Polyposis in Minority and Underserved Populations (0:15)
- Expert: Maha Mahdavinia, MD
Expert: Anjeni Keswani, MD
Host: Gerald Lee, MD
This podcast series is supported by Sanofi Regeneron.
Explore other AllergyTalk episodes